| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
|
FINANCIAL RESULTS |
||||||
|
4Q23 CONSOLIDATED RESULTS |
||||||
|
(In Ps. Millions, except percentages) |
||||||
|
|
4Q23 |
As % of Revenue |
4Q22 |
As % of Revenue |
Growth (%) |
Variation (Bps) |
|
Total Revenue |
Ps. 12,316 |
100.0% |
Ps. 9,416 |
100.0% |
30.8% |
N/A |
|
Gross Profit |
Ps. 2,011 |
16.3% |
Ps. 1,430 |
15.2% |
40.6% |
114 bps |
|
Sales Expenses |
Ps. (1,392) |
11.3% |
Ps. (991) |
10.5% |
40.5% |
78 bps |
|
Administrative Expenses |
Ps. (354) |
2.9% |
Ps. (232) |
2.5% |
52.6% |
41 bps |
|
Other (Expense) Income – Net |
Ps. (37) |
(0.3)% |
Ps. 7 |
0.1% |
n.m. |
(38) bps |
|
EBITDA |
Ps. 559 |
4.5% |
Ps. 421 |
4.5% |
32.9% |
7 bps |
Posted In: TBBB
